CD56 Antikörper (FITC)
Kurzübersicht für CD56 Antikörper (FITC) (ABIN7178523)
Target
Alle CD56 (NCAM1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Affinity purified
-
Immunogen
- Recombinant Protein
-
Isotyp
- IgG1, IgG1 kappa
-
-
-
-
Applikationshinweise
- Recommended dilution:IF:1:100-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Phosphate-buffered solution, pH 7.4, containing 0.09 % sodium azide and 0.2 % (w/v) BSA
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- CD56 (NCAM1) (Neural Cell Adhesion Molecule 1 (NCAM1))
-
Andere Bezeichnung
- NCAM1
-
Hintergrund
-
Background: COC56 reacts with CD56, a 175-220 kDa Neural Cell Adhesion Molecule (NCAM), expressed on 10-25% of peripheral blood lymphocytes, including all CD16+ NK cells and approximately 5% of CD3+ lymphocytes, referred to as NKT cells. It also is present at brain and neuromuscular junctions, certain LGL leukemias, small cell lung carcinomas, neuronally derived tumors, myeloma and myeloid leukemias. CD56 (NCAM) is involved in neuronal homotypic cell adhesion which is implicated in neural development, and in cell differentiation during embryogenesis.1. Knapp, W et al., eds. (1989) Leucocyte Typing IV: White Cell Differentiation Antigens, Oxford University Press, New York.2. Lanier LL . et al. (1991) J. Immunol. 146:4421-4426.3. Campbell, JJ et al. (2001) J. Immunol . 166:6477-6482.4. Cooper MD et al. (2001) Trends in Immunol. 22:633-640.5. Galandrini R et al. (2002) Blood. 100:4581-4589.
Aliases: N/A
-
UniProt
- P13591
Target
-